In the field of blood transfusion medicine, where guaranteeing the safety and compatibility of blood transfusions is crucial, Blood Group Antibody Screening is an essential test. The primary goal of this test is to detect any unexpected antibodies in a patient's blood, particularly those that are directed against antigens on red blood cells (RBCs). These antigens are part of the Rh, Kell, Duffy, Kidd, ABO, and other blood group systems.
The patient's blood serum or plasma is carefully examined in the context of the Blood Group Antibody Screening using a 3 Cell Panel. To do this, combine it with three different reagent red blood cell samples, each chosen based on how well it produces antigens common to a large proportion of the human population. This method is essential for the effective identification of a wide range of therapeutically relevant antibodies.
Profile Name Blood Group Antibody Screening (3 Cell Panel)
Sample Type Blood
Preparations Required No special preparation is needed for this test.
Report Time 24 Hours
Employing a 3 cell panel antibody screening technology guarantees a thorough assessment, encompassing a wide variety of possible antibodies that could be present. This is especially important in situations where accurate identification is necessary, such blood transfusions. The 3 cell panel's specificity and sensitivity support the dependability of the findings and help medical practitioners make well-informed judgments about patient care.
Pregnant women are one demographic group for which the 3 cell panel antibody screening is particularly important. By identifying antibodies that could be dangerous during pregnancy, this screening procedure helps to protect the developing fetus and the mother.
Utilizing a 3 Cell Panel for Blood Group Antibody Screening is an essential diagnostic technique that protects the integrity of blood transfusions. The focus on the antibody screening 3 cell panel highlights how important it is for effectively finding a broad variety of antibodies. Maintaining the safety and compatibility of blood products is greatly aided by this screening process, whether blood transfusions are for general use or for particular situations like pregnancy.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
3 Cell Panel Blood Group Antibody Screening is a test that finds antibodies in the blood that are directed against antigens on red blood cells. It is crucial for ensuring the safety and compatibility of blood transfusions.
This test is crucial for identifying individuals who have antibodies that may react with antigens on transfused red blood cells. This helps in selecting compatible blood for transfusion and preventing transfusion reactions.
If antibodies are detected, additional testing is performed to identify the specific antibody. The presence of antibodies can impact the selection of blood for transfusion.
Pregnant women may develop antibodies against red blood cell antigens. This is especially important in cases where the antibodies could affect the fetus.
If you have an antibody against a rare antigen, special arrangements may need to be made to find compatible blood for transfusion.
Yes, the test should be repeated anytime there is a need for a blood transfusion, as antibody profiles can change over time.
A 3 Cell Panel uses three reagent red blood cell samples for screening, while other panels might use a different number. The 3 Cell Panel is a standard approach for initial screening.
